ResMed Inc. (RMD) Stock
RMD Key Statistics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
CEO: Michael J. Farrell. Company website
RMD — Frequently Asked Questions
What is the RMD stock price today?
ResMed Inc. (RMD) trades at $224.99, down 1.50% on the day, as of Sep 20, 2026 14:59 UTC.
What is ResMed Inc.'s market cap?
ResMed Inc. has a market capitalisation of $32.64B, calculated from the live RMD share price and shares outstanding.
What is the P/E ratio of RMD?
RMD trades at a trailing P/E of 21.63, from earnings per share of $10.40 over the last twelve months.
How much revenue does ResMed Inc. make?
ResMed Inc. generated revenue of $5.65B over the trailing twelve months, which puts the stock at 5.77 times sales.
Does RMD pay a dividend?
Yes. ResMed Inc. pays a dividend yielding 0.88% on the current share price.
What is the 52-week range for RMD?
RMD has traded between $180.27 and $284.87 over the past 52 weeks, and the last price is 21.0% below that high.
Is ResMed Inc. profitable?
Yes. ResMed Inc. keeps 26.94% of revenue as net income over the trailing twelve months.
What is the analyst price target for RMD?
Wall Street analysts rate RMD Hold, with an average price target of $239.90, 6.6% above the current price.
What sector is ResMed Inc. in?
ResMed Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of ResMed Inc.?
Michael J. Farrell is the chief executive of ResMed Inc., which employs 11,370 people.
Where can I track RMD in real time?
QFI Terminal shows RMD with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See RMD live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open RMD in Terminal See plans